Please Wait
Applying Filters...
menu
    • menu
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Johnson & Johnson Innovative Medicine

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1JANSSEN PHARMACEUTICA NV Beerse BE

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    JANSSEN PHARMACEUTICA NV Beerse BE

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Itraconazole, Method 1

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    R1-CEP 1999-092 - Rev 07
    Valid
    Chemical
    2017-02-07
    1335
    blank

    01

    JANSSEN PHARMACEUTICA NV Beerse BE

    U.S.A
    RDD 2025
    Not Confirmed
    arrow

    Looking for Certificates of Suitability (CEPs) for R1-CEP 1999-092 - Rev 07 of Janssen Pharmaceutica Nv Beerse Be

    Looking for Certificates of Suitability (CEPs) for R1-CEP 1999-092 - Rev 07 of Janssen Pharmaceutica Nv Beerse Be 1

    20

    Janssen Pharmaceutica Nv Beerse Be, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Itraconazole, Method 1, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 1999-092 - Rev 07

    This Chemical Type CEP, issued on February 07, 2017, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1335 associated with this CEP further emphasizes